Skip to content
mapperlab
← Dashboard
Stock

INSP

Inspire Medical Systems, Inc.
Health CareHealth Care EquipmentLatest close $427 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
7
27 funds tracked
Ever held
9
Current + past
New this quarter
0
Exited this quarter
0

Marquee-fund ownership over time

May 14, 2021Aug 9, 2024Aug 14, 2025Feb 17, 2026
Now
7

Current holders

Sorted by tenure (longest first)
FundEntry priceLatest closeReturn on entry
Bridgewater Associates$171$42-76%
Renaissance Technologies$193$42-78%
Citadel Advisors$190$42-78%
Two Sigma Investments$190$42-78%
D.E. Shaw$190$42-78%
AQR Capital Management$190$42-78%
Millennium Management re-entered$190$42-78%

“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.

Past holders

Funds that exited at some point
FundEntry → ExitReturn
Point72 Asset Management 2× in & out→ $60-29%
Viking Global Investors→ $251+54%

Insider activity

Form 4 — officers, directors, 10%+ owners

Filed within two business days of each transaction by anyone with material insider status at Inspire Medical Systems, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.

Filings · last 30d
11
Filings · last 90d
28
Total on file
545
Recent SEC buffer
Most recent
May 19, 2026

30d / 90d windows measured from May 19, 2026 — the most recent Form 4 on file — not from today.

Showing 15 of 545 recent Form 4 filings. Browse all on EDGAR ↗

Fundamentals

XBRL · Inspire Medical Systems, Inc.

Annual figures sourced directly from Inspire Medical Systems, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.

Revenue
$911.98M
FY2025+14% YoY
Net income
$145.42M
FY2025+172% YoY
EPS (diluted)
$4.89
FY2025+179% YoY
Free cash flow(?)
$78.48M
FY2025-14% YoY

Recent SEC filings

10-K · 10-Q · 8-K · 13D/G · proxy

The most recent material filings for Inspire Medical Systems, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Millennium ManagementQ4 2025open$86$42-52%
Point72 Asset ManagementQ3 2025Q1 2026$85$60-29%
Citadel AdvisorsQ3 2024open$190$42-78%
Two Sigma InvestmentsQ3 2024open$190$42-78%
D.E. ShawQ3 2024open$190$42-78%
AQR Capital ManagementQ3 2024open$190$42-78%
Millennium ManagementQ3 2024Q3 2025$190$85-56%
Point72 Asset ManagementQ3 2024Q1 2025$190$186-2%
Renaissance TechnologiesQ3 2024open$193$42-78%
Viking Global InvestorsQ2 2022Q3 2023$164$251+54%
Bridgewater AssociatesQ2 2021open$171$41-76%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.